October 5, 2021 Comments Off on New patent for Gilead Sciences drug EPCLUSA Posted in: Patent Added Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are fourteen…
The post New patent for Gilead Sciences drug EPCLUSA appeared first on Drug…
October 5, 2021 Comments Off on New patent for Gilead Sciences drug VOSEVI Posted in: Patent Added Annual Drug Patent Expirations for VOSEVI Vosevi is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are seventeen…
The post New patent for Gilead Sciences drug VOSEVI appeared first on DrugPat…